Position in JNJ
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,543,157
+$728,017 QoQ
Shares Held
14,495
+6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. JNJ ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,543,157 | 14,495 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,815,140 | 13,603 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,470,165 | 13,322 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,171,035 | 14,213 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,254,263 | 13,593 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,936,751 | 13,392 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,967,894 | 12,143 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,937,058 | 13,253 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,222,253 | 14,048 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,921,476 | 18,639 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,689,958 | 17,271 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,753,756 | 16,637 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,078,550 | 13,410 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,325,950 | 13,167 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,150,961 | 13,167 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,343,132 | 13,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,204,386 | 12,438 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,138,546 | 12,501 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,084,319 | 12,906 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,076,712 | 12,606 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,071,303 | 12,603 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,028,942 | 12,892 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,918,914 | 12,889 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,777,000 | 12,636 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,547,202 | 11,799 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||